SEATTLE--(BUSINESS WIRE)--Northstar Neuroscience, Inc. (Nasdaq: NSTR), a developer of innovative medical devices for the treatment of neurological diseases and disorders, today announced that it has been awarded patent number 7,146,217 by the U.S. Patent and Trademark Office (USPTO) for its cortical stimulation therapy system. This patent includes important claims covering the use of cortical stimulation therapy for Northstar’s lead clinical program for stroke recovery, as well as other applications involving brain injury and other disorders. The patent, which in part includes material initially filed in the USPTO in July 2000, is one of many early neurostimulation patents and patent applications owned by Northstar.
